A Multi-center Registry Study: The Follow-up the Complications for Trans-vaginal Mesh Surgery
NCT ID: NCT04025047
Last Updated: 2019-07-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
4147 participants
OBSERVATIONAL
2019-04-10
2026-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Follow-up of Mesh/Native Tissue Complications Study(Part II)
NCT03617211
Comparison of Post-operative Symptoms After Two Surgeries for Patients With Pelvic Organ Prolapse
NCT05697796
Laparoscopic Sacral Colpopexy Versus Modified Total Pelvic Floor Reconstructive Surgery for Apical Prolapse Stage III-IV
NCT01762384
GYNECARE PROSIMA* Procedure Versus Modified Total Pelvic Floor Reconstructive Surgery for Uterine Prolapse Stage III
NCT01396109
Factors Affecting the Improvement of Severity of Concomitant USI After a Novel TVM Surgery for Women With POP
NCT03607968
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The follow-up process starts after patients have completed the operation; thus, our study does not affect patients' choice of surgical method.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Transvaginal mesh
Patients who undergo pelvic reconstruction surgery using trans-vaginal mesh (commercial mesh kits or self-cut synthesized mesh).
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* 2\) Physically or mentally unable to participate in up to 36 months of follow-up;
* 3\) Desires other surgical management of POP other than trans-vaginal mesh.
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Qilu Hospital of Shandong University
OTHER
The First Affiliated Hospital of Nanchang University
OTHER
Jiangxi Maternal and Child Health Hospital
OTHER
Fuzhou General Hospital
OTHER
Obstetrics & Gynecology Hospital of Fudan University
OTHER
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
OTHER
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
OTHER
Shanghai Jiao Tong University Affiliated Sixth People's Hospital
OTHER
Affiliated Wuhu Clinical College of Nantong University
UNKNOWN
The Second Hospital of Anhui Medical University
OTHER
Renmin Hospital of Wuhan University
OTHER
Second Xiangya Hospital of Central South University
OTHER
Changsha Hospital for Maternal and Child Health Care
OTHER
The Third Xiangya Hospital of Central South University
OTHER
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
OTHER
Shenzhen People's Hospital
OTHER
Fourth Medical Center of PLA General Hospital
OTHER
Beijing Chao Yang Hospital
OTHER
The Second Affiliated Hospital of Harbin Medical University
OTHER
Second Hospital of Jilin University
OTHER
Shengjing Hospital
OTHER
Yantai Yuhuangding Hospital
OTHER
Shanxi Coal Center Hospital
UNKNOWN
Mianyang Central Hospital
OTHER
West China Second University Hospital
OTHER
Chongqing Medical Center for Women and Children
OTHER
Southwest Hospital, China
OTHER
Shaanxi Provincial People's Hospital
OTHER
First Affiliated Hospital of Xinjiang Medical University
OTHER
People's Hospital of Xinjiang Uygur Autonomous Region
OTHER
Dalian Maternity and Child Care Hospital
OTHER
Henan Provincial People's Hospital
OTHER
Shanghai 10th People's Hospital
OTHER
Shanghai First Maternity and Infant Hospital
OTHER
Nanjing Maternity and Child Health Care Hospital
OTHER
Affiliated Renhe Hospital of China Three Gorges University, China
UNKNOWN
Guizhou Provincial People's Hospital
OTHER
The First Affiliated Hospital of the Medical College, Shihezi University，China
UNKNOWN
Yangpu District Central Hospital Affiliated to Tongji University
OTHER
Wuhan Central Hospital
OTHER
Peking Union Medical College Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
zhulan
MD, the Chief of General Gynecology Center, the Department of Obstetrics & Gynecology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lan Zhu, MD
Role: PRINCIPAL_INVESTIGATOR
Peking Union Medical College Hospital, Chinese Academy of Medicine Sciences
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Peking Union Medical College Hospital, Chinese Academy of Medicine Sciences
Beijing, Beijing Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
JS-1979
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.